Siconolfi-Baez L, Banerji M A, Lebovitz H E
Department of Medicine, State University of New York, Brooklyn 11203.
Diabetes Care. 1990 Aug;13 Suppl 3:2-8. doi: 10.2337/diacare.13.3.2.
This study describes and characterizes a putative sulfonylurea receptor. The radioligand used was [3H]glipizide (9 Ci/mmol). The beta-cell plasma membranes were derived from a transplantable rat insulinoma generated by subcutaneous injection of RINm5F cells and purified by ultracentrifugation on a 15-55% sucrose gradient. Specific binding of [3H]glipizide to purified beta-cell plasma membranes was determined to be maximal at temperatures of 4-23 degrees C, pH 7.3, and an incubation of 2 h. Scatchard analysis indicated a single binding site with Kd = 7 nM and sulfonylurea binding of 0.93 pmol/mg membrane protein. Displacement of [3H]glipizide from the purified beta-cell plasma membranes by various sulfonylureas and their analogues correlated well with their known hypoglycemic and insulin-releasing activities. Various agents, including nutrients, agents affecting Ca2+ flux, gastrointestinal hormones, and pancreatic hormones, had no effect on [3H]glipizide binding to the beta-cell plasma membranes. Putative sulfonylurea receptors on beta-cell and brain cell plasma membranes have been reported by several groups of investigators. Sulfonylurea binding to the beta-cell is hypothesized to close an ATP-sensitive K+ channel, which leads to depolarization of the membrane and activation of a voltage-dependent Ca2+ channel.
本研究描述并表征了一种假定的磺酰脲受体。所使用的放射性配体是[3H]格列吡嗪(9 Ci/mmol)。β细胞质膜来源于通过皮下注射RINm5F细胞产生的可移植大鼠胰岛素瘤,并通过在15 - 55%蔗糖梯度上进行超速离心纯化。[3H]格列吡嗪与纯化的β细胞质膜的特异性结合在4 - 23℃、pH 7.3以及2小时孵育条件下测定为最大。Scatchard分析表明存在一个单一结合位点,Kd = 7 nM,磺酰脲结合量为0.93 pmol/mg膜蛋白。各种磺酰脲及其类似物从纯化的β细胞质膜上置换[3H]格列吡嗪的情况与其已知的降血糖和胰岛素释放活性密切相关。包括营养物质、影响Ca2+通量的试剂、胃肠激素和胰腺激素在内的各种试剂对[3H]格列吡嗪与β细胞质膜的结合均无影响。几组研究人员都报道了β细胞和脑细胞质膜上存在假定的磺酰脲受体。据推测,磺酰脲与β细胞的结合会关闭一个ATP敏感性钾通道,从而导致膜去极化并激活电压依赖性钙通道。